Final report of phase 1 study of the DOT1L inhibitor, pinometostat (EPZ-5676), in children with relapsed or refractory MLL-r acute leukemia Meeting Abstract


Authors: Shukla, N.; Wetmore, C.; O'Brien, M. M.; Silverman, L. B.; Brown, P.; Cooper, T. M.; Thomson, B.; Blakemore, S. J.; Daigle, S.; Ben, Suttle; Waters, N. J.; Krivstov, A. V.; Armstrong, S. A.; Ho, P. T.; Gore, L.
Abstract Title: Final report of phase 1 study of the DOT1L inhibitor, pinometostat (EPZ-5676), in children with relapsed or refractory MLL-r acute leukemia
Meeting Title: 58th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 128
Issue: 22
Meeting Dates: 2016 Dec 3-6
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2016-12-02
Language: English
ACCESSION: WOS:000394452304097
PROVIDER: wos
Notes: Meeting Abstract: 2780 -- Source: Wos